Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

CNY 21.86

(1.49%)

Revenue Summary of Vcanbio Cell & Gene Engineering Corp., Ltd

  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest annual revenue in 2023 was 1.58 Billion CNY , up 2.24% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest quarterly revenue in 2024 Q3 was 403.61 Million CNY , down -0.17% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a annual revenue of 1.55 Billion CNY in annual revenue 2022, up 1.27% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a annual revenue of 1.53 Billion CNY in annual revenue 2021, up 16.41% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly revenue of 403.61 Million CNY for 2024 Q3, down -0.17% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly revenue of 404.3 Million CNY for 2024 Q2, up 2.85% from previous quarter.

Annual Revenue Chart of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Created with Highcharts 11.1.0YearsRevenue1994199619982000200220042006200820102012201420162018202020220 CNY500000000 CNY1000000000 CNY1500000000 CNY2000000000 CNY

Historical Annual Revenue of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Year Revenue Revenue Growth
2023 1.58 Billion CNY 2.24%
2022 1.55 Billion CNY 1.27%
2021 1.53 Billion CNY 16.41%
2020 1.31 Billion CNY -4.9%
2019 1.38 Billion CNY 5.02%
2018 1.32 Billion CNY 51.62%
2017 870.91 Million CNY 3.94%
2016 837.9 Million CNY 18.18%
2015 708.99 Million CNY 48.68%
2014 476.86 Million CNY 31.98%
2013 361.3 Million CNY 20.3%
2012 300.34 Million CNY 21.73%
2011 246.73 Million CNY -8.1%
2010 268.47 Million CNY -12.76%
2009 307.74 Million CNY 6.82%
2008 288.1 Million CNY -26.54%
2007 392.18 Million CNY -3.72%
2006 407.35 Million CNY 14.95%
2005 354.36 Million CNY 25.99%
2004 281.25 Million CNY -13.47%
2003 325.03 Million CNY 4.41%
2002 311.3 Million CNY 5.15%
2001 296.05 Million CNY 47.34%
2000 200.93 Million CNY 100.85%
1999 100.04 Million CNY -46.29%
1998 186.28 Million CNY -37.57%
1997 298.37 Million CNY 17.04%
1996 254.93 Million CNY 73.91%
1995 146.59 Million CNY -16.65%
1994 175.88 Million CNY 44.07%
1993 122.08 Million CNY 0.0%

Peer Revenue Comparison of Vcanbio Cell & Gene Engineering Corp., Ltd

Name Revenue Revenue Difference
Beijing Tiantan Biological Products Co., Ltd. 5.18 Billion CNY 69.313%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 2.22 Billion CNY 28.578%
Jinyu Bio-technology Co., Ltd. 1.59 Billion CNY 0.532%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 17.28 Billion CNY 90.801%
Zhejiang Ausun Pharmaceutical Co., Ltd. 816.76 Million CNY -94.637%
DaShenLin Pharmaceutical Group Co., Ltd. 24.43 Billion CNY 93.495%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 5.47 Billion CNY 70.974%
GuiZhou SanLi Pharmaceutical Co.,Ltd 1.61 Billion CNY 1.77%
Pulike Biological Engineering, Inc. 1.25 Billion CNY -26.904%
Beijing Konruns Pharmaceutical Co.,Ltd. 920.01 Million CNY -72.794%
Shanghai Hile Bio-Technology Co., Ltd. 240.72 Million CNY -560.395%
Qingdao Vland Biotech INC. 1.18 Billion CNY -33.7%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 784.34 Million CNY -102.681%
Aurisco Pharmaceutical Co.,Ltd. 1.26 Billion CNY -25.916%
Zhejiang East Asia Pharmaceutical Co., Ltd. 1.35 Billion CNY -17.198%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 1.9 Billion CNY 16.558%
Mabwell (Shanghai) Bioscience Co., Ltd. 127.68 Million CNY -1145.02%
Beijing Hotgen Biotech Co., Ltd. 541.25 Million CNY -193.713%
Assure Tech (Hangzhou) Co., Ltd. 503.35 Million CNY -215.824%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 1.02 Billion CNY -54.891%
Cabio Biotech (Wuhan) Co., Ltd. 443.8 Million CNY -258.205%
Shanghai Shen Lian Biomedical Corporation 301.48 Million CNY -427.294%
Nanjing Vazyme Biotech Co., Ltd. 1.28 Billion CNY -23.852%
Shandong Kexing Bioproducts Co,.Ltd 1.25 Billion CNY -26.265%
Shanghai Junshi Biosciences Co., Ltd. 1.48 Billion CNY -7.208%
Shanghai Model Organisms Center, Inc. 366.54 Million CNY -333.7%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 385.41 Million CNY -312.47%
Xiamen Amoytop Biotech Co., Ltd. 2.1 Billion CNY 24.311%
Novogene Co., Ltd. 2 Billion CNY 20.598%
Shanghai ZJ Bio-Tech Co., Ltd. 268.13 Million CNY -492.878%
Chengdu Olymvax Biopharmaceuticals Inc. 496.11 Million CNY -220.432%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 1.01 Billion CNY -56.772%
Shanghai Haohai Biological Technology Co., Ltd. 2.63 Billion CNY 39.667%
Jiangsu Bioperfectus Technologies Co., Ltd. 403.17 Million CNY -294.297%
Jiangsu Aidea Pharmaceutical Co., Ltd. 411.32 Million CNY -286.484%
Chengdu Easton Biopharmaceuticals Co., Ltd. 1.11 Billion CNY -42.305%
Sinocelltech Group Limited 1.88 Billion CNY 15.77%
Wuhan Keqian Biology Co.,Ltd 1.06 Billion CNY -49.4%
Shanghai Allist Pharmaceuticals Co., Ltd. 1.99 Billion CNY 20.178%
Anhui Huaheng Biotechnology Co., Ltd. 1.93 Billion CNY 17.982%
Youcare Pharmaceutical Group Co., Ltd. 4.19 Billion CNY 62.116%
Jiangsu gdk Biotechnology Co., Ltd. 134.59 Million CNY -1081.148%
Beijing Kawin Technology Share-Holding Co., Ltd. 1.41 Billion CNY -12.586%
Hangzhou Biotest Biotech Co.,Ltd. 442.11 Million CNY -259.576%